Search Within

Survivorship Research

Formats
  1. Journal Article (9011)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (367)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9328)
  2. Population Sciences Research Program (5758)
  3. Solid Tumor Oncology Division (5247)
  4. Surgery (5205)
  5. Epidemiology and Biostatistics (3669)
  6. Division of Subspecialty Medicine (3268)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (702)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (391)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (604)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1560)
  4. Wiley Blackwell (819)
  5. Oxford University Press (792)
  6. American Society of Hematology (790)

More Publishers

Results (15971)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunotherapy related patient-reported outcomes from five randomized controlled trials in patients with triple negative breast cancer: A systematic review
    Meeting Abstract

    Sha, C.; Liu, M.; Goldberg, J.; Norton, L.; Robson, M. E.; Zhi, I.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Randomized PROSTATE-IQ trial to reduce ADT treatment burden for patients with biochemical recurrence after prostatectomy
    Meeting Abstract

    Hoffman, K. E.; Kollmeier, M.; Nguyen, P. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Prescribers of opioids for head and neck cancer (HNC) survivors
    Meeting Abstract

    Salz, T.; Meza, A. M.; Bradshaw, P. T.; Jinna, S.; Moryl, N.; Kriplani, A.; Tringale, K. R.; Flory, J.; Korenstein, D.; Lipitz-Snyderman, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial
    Meeting Abstract

    Iyengar, N. M.; Salehi, E.; Lavery, J. A.; Chan, O.; Lehman, S.; Michalski, M. G.; Fickera, G.; Carlson, A.; Harrison, J.; Underwood, W. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Racial and ethnic differences in patient-reported provider communication among patients with cancer
    Meeting Abstract

    Swami, N.; Patel, T. A.; Dee, E. C. C.; Thom, B.; Chino, F.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Yeh, C.; Harrold, E.; Keane, F.; Sinopoli, J. C.; Foote, M. B.; Cercek, A.; Yaeger, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save